• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Compounds of the formula <IMAGE> wherein R1 is chlorine, bromine or alkyl of 1 to 3 carbon atoms; R2 is hydrogen or, when R1 is alkyl, chlorine or bromine; R1 and R2, together with each other, are straight alkylene of 3 to 4 carbon atoms; R3 is hydrogen, fluorine, chlorine, bromine, alkyl of 1 to 2 carbon atoms; hydroxyl or trifluoromethyl; and R4 is hydrogen, straight or branched alkyl of 1 to 4 carbon atoms or phenyl lower alkyl; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as antidepressants.
    公开号:SU718011A3
    申请号:SU782673554
    申请日:1978-10-10
    公开日:1980-02-25
    发明作者:Шнейдер Клаус；Гейнц Вебер Карл-；Лангбейн Адольф；Дитрих Бехтель Вольф；Беке Карин
    申请人:Кх Берингер Зон (Фирма)；
    IPC主号:
    专利说明:

    37
    salts or, if in a compound of general formula i, R4 is hydrogen, exposed to an alkylating agent, or, if RI is hydrogen, is chlorinated or brominated, or if Rj is hydrogen and RI is an alkyl radical with 1 to 3 carbon atoms, it is chlorinated or bromination
    and the resulting desired products are recovered.
    one . .
    I - y
    Cyclization is carried out using such
    acids, such as phosphoric or polyphosphoric, concentrated sulfuric or trifluoroacetic acid, in the absence of solvents, scientific research institute with the addition of one or more inert solvents, such as methylene chloride, chloroform, dioxane, ethylene dichloride, benzene, toluene, xylene or chlorinated benzenes, at temperatures from room to temperature Cav. KI 5 sno nn-sng-sn-one Kz cav and u with CL N ---; --- 3 CH N-CHg-CH-OHR S
    14
    solvent penalties or
    solvent mixtures.
    The desired products are isolated in free form or in the form of salts with acids, such as hydrohalic acid, sulfuric acid, phosphoric acid, amynosulfonic acid, formic acid, acetic acid, propionic acid, lactic acid, glycol, gluconic acid, Maleic acid, amber, vinna, benzoic, salicylic acid, gluconic acid, acetic acid, gluconic acid, maleic acid, succinic acid, formic acid, acetic acid, propionic acid, lactic acid. , p-toluenesulfonic or hydroxyethanesulfonic acid.
    The starting materials of the general formula (tl) are obtained according to the following reaction scheme, either through Schiff osation formed with 2-fench1-2-hydroxyegylamine, or through 2-Tg-nylmethylamine, which is reacted with either bromoacetophenone or styrene oxide. CH2-NHRjt Бг-СНг-С 2 1ТАВЩ. |
    Example 1. 2,6-Dimethyl-4- (i-bromophenyl) - 2,3-c-thienopiperidine.
    A solution of 50 g (0.355 mol) of 2-methyl-5- (methylaminomethyl) -aophene, 98.7 g of i-bromo-b-bromoacetophenone in 500 ml of stanol is stirred at room temperature for 2 hours with an equivalent amount of potassium carbonate. 1b, 9 g of sodium borane is added to the portioned mg solution cooled to 5 ° C and stirred for 3 hours. To remove excess sodium borane, civiecb is poured onto ice, extracted with Methylenchloride and the solvent is distilled off. The residue is chromatographed on silica gel, the solvent is methylene chloride. 96 g (79.4%) of i-methyl-N-2-methylthienyl- (5) -methyl -2- (p-bromophenyl) -2-hydroxyistilamine are obtained, m.p. 145-147 ° C.
    30 g (0.088 mol) of the obtained ztilamine are stirred at 30 ° C for 10 min.
    450 g of polyphosphoric acid, briefly heated to 90 ° C and slowly cooled. The mixture is then decomposed with water, neutralized with ammonia and extractable with ethyl acetate. This solution is purified with activated carbon and filtered. The solvent is then distilled off and the residue is dissolved in 800 ml of isopropanol; using the hydrochloride solution in ether, the hydrochloride of this compound was isolated; yield 20.5 g (65%), m.p. 258-260 ° С (from isopropanol).
    Example 2. 2,6-Dimethyl-4- (i-bromophenyl) {2, 3-C1-thienopiperidine.
    3.45 g (0.01 mol) of 2-methyl-4- (p-bromophenyl) hydrochloride, 3-c-thienopiperidyl 1a are mixed, and the pl. 282-283 ° C, 50 ml of ether, 2.8 g (0.02 mol) of potassium carbonate and 1.5 g (0.01 mol) of methyl iodide and heated for 2 hours in a water bath. The inorganic salts are filtered off, the solvent is distilled off, and the hydrochloride is removed from the residue with a solution of hydrochloride in ether, which is recrystallized from isopropanol. The output of 3.25 g (91%), so pl. 258-260 ° C. Example 3. 2-Chloro-4- (A (-hydroxyphennl) - {2, 3-c) -thienopiperidine. 14.6 g (0.1 mol) 2-chloro-5-thiophenaldehy; yes, 18.9 g (0.1 mol) of 1- (l-hydroxyfensch1) -2-aminoethanol gddrochloride and 14 g of potassium carbonate in 200 ml of benzene with 0.2 ml of trifluorooxy acid are heated at the boil for 4 h while simultaneously distillation of water. To the reaction mixture cooled to 5 ° C was slowly added 4.2 g of sodium borane dissolved in 100 MP of methanol. The reaction mass is still stirred for 30 min at. The solvent is distilled off in vacuo, the residual HTJK is decomposed into excess sodium borane with hydrochloric acid, then neutralized with ammonia, extracted with methyl chloride and the solvent is distilled off. The resulting 29.6 g of oil is dissolved in 150 ml of methylene chloride and 120 ml of concentrated sulfuric acid are added dropwise at 0 ° C. Mix ne | stir for 30 minutes at 0 ° C, then poured onto ice, neutralize with ammonia, extract with ethyl acetate and extract the solvent. The yield of 8.4 g (32%), so pl. 188-189e | nz ethyl acetate). | Example 4. 2,6-Dimesh1 "3 bromo-4- (-bromo nyl), 3-c-thienopipervdin. 3 g (0.008 mol) of 2,6 dimethyl-4- (l-bromophenyl) - {2,3-c-thienopnperidine hydrochloride and 6 8 g of aluminum bromide are dissolved in 100 ml of glacial acetic acid. 1.4 g of bromine was slowly added dropwise to the solution cooled to 15 ° C and stirred at room temperature for several jiacoB until the reaction was complete. The mixture is then decomposed with ice water and neutralized. The residue is purified by chromatography on silica gel, methylene chloride / methanol (95: 5). After adding a solution of the hydrochloride in ether, 2.25 g (61%) of the hydrochloride of the compound indicated are obtained, m.p. 261-262 ° C. Appro. 5. 5-Chloro-4-phenyl-6-metsh-2.3 s-thienopiperidine. And g (0.068 mol) of 2-chloro-5- (methylaminomethyl) thiophene in 50 ml of methanol with 8.2 g (0.068 mol) of styrene oxide is heated to reflux for 2 h. The solvent is removed in vacuo and the residue is purified by chromatography on silica gel, the eluent is methylene chloride. 12.1 g of oil are obtained, which is heated to 100 ml of dioxane with 6.5 g of phosphorus oxide and then from 5.9 g to five. phosphorus oxides. Phosphorus bleach is removed and the solvent is removed in vacuo, the residue is decomposed with water, neutralized, extracted with methylene chloride and purified by chromatography. By treating the residue with a solution of hydrochloride in ether, 17.9 g (83%) of the hydrochloride of the indicated dieneum so obtained are obtained. 223-225С (from ethanol). Compounds of the general formula 1 given in the table can be prepared in a similar way.
    Table continuation
    权利要求:
    Claims (1)
    [1]
    29.07.78 at B 2 - a chlorine or bromine atom, if Βι means an alkyl group with 1-3 atoms of 45 carbon; 8ι and I g together mean a three or four membered alkylene chain; B 3 hydroxy; B 4 - hydrogen or lower phenylalkyl radical.
    50 Sources of information
    taken into account in the examination
    1. The patent of France No. 1486647, cl. From 07 0495/02 'published 1977.
    TsNIIPI Order 9870/71 Circulation: 495 Subscription
    Branch PPP "Patent", Uzhgorod Projecto st., 4
    类似技术:
    公开号 | 公开日 | 专利标题
    FR2654104A1|1991-05-10|NOVEL 1,2-BENZISOXAZOLE DERIVATIVES, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
    US4337263A|1982-06-29|1-Aryl-4-γ-arylsulphonyl-3-aminopropoxy-1H-pyrazoles and their use as hypolipemiant and hypocholesterolemiant agents
    US4311840A|1982-01-19|2,3,6,7-Tetrahydro-2-thioxo-4H-oxazolo[3,2-a]-1,3,5 triazin-4-ones
    JP2556722B2|1996-11-20|Novel sulfonamide compound
    SU659081A3|1979-04-25|Method of obtaining phenylethylamines or salts thereof
    EP0040860B1|1984-03-14|Dibenzoxazepine derivative, process for preparing the same and pharmaceutical composition comprising the same
    SU718011A3|1980-02-25|Method of producing phenylthieno-| piperidine derivatives or salts thereof
    US4102886A|1978-07-25|Process for the preparation of benzo|quinolizidine derivatives
    US4046778A|1977-09-06|Processes for the preparation of 4-hydroxy-2H-1-benzothiopyran-3-carboxamide 1,1-dioxides
    HU181742B|1983-11-28|Process for producing new azetidinone derivatives
    US4007203A|1977-02-08|4-|-2H-1-benzothiopyran-3-carboxanilide
    KR880001320B1|1988-07-23|Process for the preparation of 2-cyclic amino-2-|acetic acid ester derivatives
    US4419355A|1983-12-06|Condensed as-triazine derivatives and method of using the same
    EP0070531B1|1988-03-02|Tetrahydronaphthoxazoles
    US4217452A|1980-08-12|Synthesis for the preparation of tetracyclic compounds
    GB1594450A|1981-07-30|1,3-oxathiolane sulphoxides and their use in the preparation of 5,6-dihydro-2-methyl-1,4-oxathiin derivatives
    EP0090275B1|1987-10-28|Isoxazole | pyridines
    US3723466A|1973-03-27|Tricyclic compounds
    CA1094073A|1981-01-20|N-carbonylamino-tetrahydropyridyl derivatives
    US4152334A|1979-05-01|Process for preparing 5,6-dihydro-2-methyl-1,4-oxathiin derivatives
    CA2012569A1|1990-09-22|Benzothiopyranylamines
    CA1221966A|1987-05-19|Hydroxyimino and alkoxyimino derivatives of 1,4-dihydropyridine, process for the preparation thereofand pharmaceutical compositions therefrom
    US3947578A|1976-03-30|Omega-[4-|-piperidino]-alkyl-arylketones as nevroleptics
    US6127362A|2000-10-03|9,10-diazatricyclo[4,4,1,12,5 ] decane and 2,7-diazatricyclo [4,4,0,03,8 ] decane derivatives having analgesic activity
    US4091095A|1978-05-23|Phosphinyl compounds
    同族专利:
    公开号 | 公开日
    IE782050L|1979-04-15|
    BG28715A3|1980-06-16|
    US4322423A|1982-03-30|
    CS204036B2|1981-03-31|
    JPS5470296A|1979-06-05|
    DD139581A5|1980-01-09|
    IL55727D0|1978-12-17|
    FI783125A|1979-04-16|
    IT1109215B|1985-12-16|
    LU80366A1|1979-11-07|
    FI63942B|1983-05-31|
    DK150158B|1986-12-22|
    FR2405948B1|1981-11-06|
    NL7810307A|1979-04-18|
    CA1113095A|1981-11-24|
    RO75532A|1980-11-30|
    SE442510B|1986-01-13|
    PL126597B1|1983-08-31|
    FR2405948A1|1979-05-11|
    AU4069878A|1980-04-17|
    IL55727A|1982-01-31|
    ATA710978A|1982-02-15|
    DK458078A|1979-04-16|
    GB2007219A|1979-05-16|
    FI63942C|1983-09-12|
    HU176486B|1981-03-28|
    NZ188645A|1981-05-29|
    IE47455B1|1984-03-21|
    AU522759B2|1982-06-24|
    AT368504B|1982-10-25|
    NO151324B|1984-12-10|
    CH644126A5|1984-07-13|
    PT68656A|1978-11-01|
    NO151324C|1985-03-20|
    SE7810728L|1979-04-15|
    GR65251B|1980-07-31|
    NO783481L|1979-04-18|
    YU240178A|1982-08-31|
    ZA785769B|1980-06-25|
    GB2007219B|1982-07-21|
    ES474218A1|1979-04-01|
    DK150158C|1987-07-06|
    PL210271A1|1979-09-24|
    IT7851501D0|1978-10-13|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3651068A|1969-11-13|1972-03-21|Colgate Palmolive Co|Derivatives of 1 2 3 4-tetrahydrobenzothienopyridines|
    FR2315274B1|1975-06-27|1979-08-10|Parcor|
    FR2358150B1|1976-07-13|1978-12-15|Parcor|
    GB1576511A|1977-03-29|1980-10-08|Parcor|Thieno and pyridines process for their preparation and therapeutic applications thereof|DE2927294A1|1979-07-06|1981-01-08|Boehringer Sohn Ingelheim|NEW 4-PHENYL-4,5,6,7-TETRAHYDROPYRROLO ANGLE CLAMP ON 2.3-C ANGLE CLAMP FOR PYRIDINE, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS|
    US4282227A|1980-05-22|1981-08-04|Smithkline Corporation|Renal vasodilating 3,4-dihydroxyphenyltetrahydrothienopyridines|
    DD210278A5|1982-03-05|1984-06-06|Boehringer Ingelheim Kg|PROCESS FOR PREPARING NEW BASIC SUBSTITUTED 4-PHENYL-4,5,6,7-TETRAHYDRO-THIENO-PYRIDINE|
    IL71661D0|1983-04-27|1984-07-31|Boehringer Ingelheim Kg|4-phenyl-tetrahydro-furano-pyridines,their preparation and pharmaceutical compositions containing them|
    US4572911A|1984-08-02|1986-02-25|Mcneilab, Inc.|Hexahydroindolinzine compounds, pharmaceutical compositions and methods and intermediates|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    DE19772746443|DE2746443C2|1977-10-15|1977-10-15|4-Phenyl-thieno- [2,3-c] -piperidines, processes for their preparation and pharmaceutical compositions containing them|
    DE19782833378|DE2833378A1|1978-07-29|1978-07-29|Antidepressant 4-phenyl-thieno-piperidine derivs. - prepd. by cyclising N-thenyl-N-2-hydroxy:phenethyl-amine|
    [返回顶部]